WOK · XBRL financial data
WORK Medical Technology Group financial statements, every fiscal year
The same tables from 2 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (WOK's year ends in late September)
| In thousands of dollars | Sep 30, 2024 | Sep 30, 2025 |
|---|---|---|
| Gross profit | 2,868 | 2,345 |
| Research and development | 303 | 435 |
| General and administrative | 4,558 | 2,327 |
| Total operating expenses | 6,914 | 4,841 |
| Interest income | 12 | 182 |
| Interest expense | 558 | 504 |
| Other income (expense) | 579 | 135 |
| Income tax expense (benefit) | (125) | 119 |
| Net income (loss) | (3,492) | (1,073) |
| Earnings per share, basic USD per share | (0.27) | (0.04) |
| Earnings per share, diluted USD per share | (0.27) | (0.04) |
| Weighted average shares, basic thousands of shares | 12,705 | 28,983 |
| Weighted average shares, diluted thousands of shares | 12,705 | 28,983 |
Balance sheet
CSVFiscal years (WOK's year ends in late September)
| In thousands of dollars | Sep 30, 2024 | Sep 30, 2025 |
|---|---|---|
| Cash and cash equivalents | 6,558 | 4,089 |
| Accounts receivable | 1,649 | 616 |
| Inventory | 3,184 | 2,455 |
| Prepaid and other current assets | 1,633 | 1,281 |
| Total current assets | 20,827 | 20,455 |
| Property and equipment, net | 11,372 | 10,588 |
| Right-of-use asset | — | 26 |
| Total assets | 36,251 | 33,156 |
| Accounts payable | 1,497 | 1,725 |
| Total current liabilities | 20,180 | 11,971 |
| Lease liability, non-current | — | 19 |
| Total liabilities | 20,180 | 11,992 |
| Retained earnings | 6,076 | 4,959 |
| Total stockholders' equity | 13,186 | 18,339 |
| Total liabilities and equity | 36,251 | 33,156 |
| Common shares outstanding (cover page) thousands of shares | 14,592 | — |
Cash flows
CSVFiscal years (WOK's year ends in late September)
| In thousands of dollars | Sep 30, 2024 | Sep 30, 2025 |
|---|---|---|
| Net income (loss) | (3,492) | (1,073) |
| Net cash from operating activities | (2,228) | 6,244 |
| Purchases of property and equipment | 9,225 | 1,333 |
| Net cash from investing activities | (9,064) | (7,608) |
| Proceeds from long-term debt | 13,395 | 17,955 |
| Net cash from financing activities | 15,657 | (898) |
| Net change in cash | 4,920 | (2,469) |
Compare with peers
SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
- A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| WORK Medical Technology Group | 4,089 | not reported | year only | not reported | — | 20-FSep 30, 2025 |
| Adagio Medical Holdings | 7,740 | 0 | (5,260)* | 22.2M | 1.5 quarters | 10-QJun 30, 2026 |
| Aethlon Medical | 4,934 | not reported | (1,897) | 711,136 | 2.6 quarters | 10-QJun 30, 2026 |
| Acutus Medical | 14,019 | 7,130* | (4,058)* | 29.9M | 3.5 quarters | 10-KDec 31, 2024 |
| ALR Technologies SG | 20 | not reported | year only | 645.5M | — | 20-FDec 31, 2025 |
| Allurion Technologies | 5,056 | 2,947 | (3,221) | 15.0M | 1.6 quarters | 10-QMar 31, 2026 |
| Autonomix Medical | 3,460 | 0 | (3,544) | 971,043 | 1.0 quarters | 10-QJun 30, 2026 |
| Angiodynamics | 33,973 | 80,915 | (15,330) | 42.1M | 2.2 quarters | 10-QAug 31, 2026 |
| Anika Therapeutics | 38,412 | 32,610 | (684)* | 13.4M | 56.2 quarters | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.